These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15239143

  • 1. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
    Albrecht S, Hartmann W, Houshdaran F, Koch A, Gärtner B, Prawitt D, Zabel BU, Russo P, Von Schweinitz D, Pietsch T.
    Int J Cancer; 2004 Sep 10; 111(4):627-32. PubMed ID: 15239143
    [Abstract] [Full Text] [Related]

  • 2. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W, Waha A, Koch A, Goodyer CG, Albrecht S, von Schweinitz D, Pietsch T.
    Am J Pathol; 2000 Oct 10; 157(4):1393-403. PubMed ID: 11021841
    [Abstract] [Full Text] [Related]

  • 3. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
    Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Deimling A, Pietsch T.
    Cancer Res; 1994 Oct 01; 54(19):5041-4. PubMed ID: 7923113
    [Abstract] [Full Text] [Related]

  • 4. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
    Montagna M, Menin C, Chieco-Bianchi L, D'Andrea E.
    J Cancer Res Clin Oncol; 1994 Oct 01; 120(12):732-6. PubMed ID: 7798299
    [Abstract] [Full Text] [Related]

  • 5. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T.
    J Pathol; 2004 Dec 01; 204(5):546-54. PubMed ID: 15538750
    [Abstract] [Full Text] [Related]

  • 6. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
    Fukuzawa R, Umezawa A, Ochi K, Urano F, Ikeda H, Hata J.
    Int J Cancer; 1999 Aug 12; 82(4):490-7. PubMed ID: 10404060
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of molecular genetic alterations in hepatoblastoma.
    von Schweinitz D, Kraus JA, Albrecht S, Koch A, Fuchs J, Pietsch T.
    Med Pediatr Oncol; 2002 Feb 12; 38(2):104-8. PubMed ID: 11813174
    [Abstract] [Full Text] [Related]

  • 8. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.
    Yamada HY, Gorbsky GJ.
    Oncogene; 2006 Mar 02; 25(9):1330-9. PubMed ID: 16314844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity on chromosome 11p15.5 and relapse in hepatoblastomas.
    Chitragar S, Iyer VK, Agarwala S, Gupta SD, Sharma A, Wari MN.
    Eur J Pediatr Surg; 2011 Jan 02; 21(1):50-3. PubMed ID: 21053162
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
    Wirths O, Waha A, Weggen S, Schirmacher P, Kühne T, Goodyer CG, Albrecht S, Von Schweinitz D, Pietsch T.
    Lab Invest; 2003 Mar 02; 83(3):429-34. PubMed ID: 12649343
    [Abstract] [Full Text] [Related]

  • 13. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain.
    Cooper PR, Smilinich NJ, Day CD, Nowak NJ, Reid LH, Pearsall RS, Reece M, Prawitt D, Landers J, Housman DE, Winterpacht A, Zabel BU, Pelletier J, Weissman BE, Shows TB, Higgins MJ.
    Genomics; 1998 Apr 01; 49(1):38-51. PubMed ID: 9570947
    [Abstract] [Full Text] [Related]

  • 14. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA, Simms LA, Little MH, Algar EM, Smith PJ.
    Genes Chromosomes Cancer; 1993 Oct 01; 8(2):104-11. PubMed ID: 7504513
    [Abstract] [Full Text] [Related]

  • 15. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
    Iolascon A, Giordani L, Moretti A, Basso G, Borriello A, Della Ragione F.
    Hepatology; 1998 Apr 01; 27(4):989-95. PubMed ID: 9537438
    [Abstract] [Full Text] [Related]

  • 16. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
    Zogopoulos G, Albrecht S, Pietsch T, Alpert L, von Schweinitz D, Lefèbvre Y, Goodyer CG.
    Cancer Res; 1996 Jul 01; 56(13):2949-53. PubMed ID: 8674047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.